An update on hepatitis C virus.

Chronic hepatitis caused by hepatitis C virus infection is one of the leading causes of liver cirrhosis and hepatocellular carcinoma globally. Over the last few years, there have been significant advances in our understanding of the immunopathogenesis of this infection, as well as revolutionary deve...

Full description

Bibliographic Details
Main Authors: Klenerman, P, Fitzmaurice, K
Format: Journal article
Language:English
Published: Royal College of Physicians 2015
_version_ 1826295473513693184
author Klenerman, P
Fitzmaurice, K
author_facet Klenerman, P
Fitzmaurice, K
author_sort Klenerman, P
collection OXFORD
description Chronic hepatitis caused by hepatitis C virus infection is one of the leading causes of liver cirrhosis and hepatocellular carcinoma globally. Over the last few years, there have been significant advances in our understanding of the immunopathogenesis of this infection, as well as revolutionary developments in the therapeutic armamentarium. The introduction of a number of new oral antiviral agents is already delivering major benefits to patients as they are generally well tolerated and are associated with excellent response rates in the majority. Nonetheless, a number of clinical scenarios remain challenging and research is ongoing in these areas. In this update, we review developments in both basic as well as translational research in the field.
first_indexed 2024-03-07T04:01:35Z
format Journal article
id oxford-uuid:c4c07269-826c-4cfa-8928-b3fe5f91e729
institution University of Oxford
language English
last_indexed 2024-03-07T04:01:35Z
publishDate 2015
publisher Royal College of Physicians
record_format dspace
spelling oxford-uuid:c4c07269-826c-4cfa-8928-b3fe5f91e7292022-03-27T06:25:53ZAn update on hepatitis C virus.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c4c07269-826c-4cfa-8928-b3fe5f91e729EnglishSymplectic Elements at OxfordRoyal College of Physicians2015Klenerman, PFitzmaurice, KChronic hepatitis caused by hepatitis C virus infection is one of the leading causes of liver cirrhosis and hepatocellular carcinoma globally. Over the last few years, there have been significant advances in our understanding of the immunopathogenesis of this infection, as well as revolutionary developments in the therapeutic armamentarium. The introduction of a number of new oral antiviral agents is already delivering major benefits to patients as they are generally well tolerated and are associated with excellent response rates in the majority. Nonetheless, a number of clinical scenarios remain challenging and research is ongoing in these areas. In this update, we review developments in both basic as well as translational research in the field.
spellingShingle Klenerman, P
Fitzmaurice, K
An update on hepatitis C virus.
title An update on hepatitis C virus.
title_full An update on hepatitis C virus.
title_fullStr An update on hepatitis C virus.
title_full_unstemmed An update on hepatitis C virus.
title_short An update on hepatitis C virus.
title_sort update on hepatitis c virus
work_keys_str_mv AT klenermanp anupdateonhepatitiscvirus
AT fitzmauricek anupdateonhepatitiscvirus
AT klenermanp updateonhepatitiscvirus
AT fitzmauricek updateonhepatitiscvirus